EGFR and non-small cell lung carcinoma: Some patients harbored several alterations as exemplified by a patient with EGFR-mutant non-small cell lung carcinoma where repeated CSF sequencing identified the emergence of multiple different EGFR mutations in response to first and third-generation EGFR inhibitors (Fig. 3c).